| Project/Area Number |
17K09306
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
General internal medicine(including psychosomatic medicine)
|
|---|
| Research Institution | Kyushu University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2017-04-01 – 2020-03-31
|
| Project Status |
Completed (Fiscal Year 2019)
|
| Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2019: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2018: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2017: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
|---|
| Keywords | マインドフルネス / マインドフルネス・イーティング / 認知行動療法 / リバウンド / RCT / むちゃ食い / 情動的摂食 / 肥満 / マインドフル・イーティング / 肥満症 / 腸内細菌 / 味覚 |
|---|
| Outline of Final Research Achievements |
The purpose of this randomized, controlled study was to examine the effectiveness of a weight loss program that included mindfulness (MF) or cognitive behavioral therapy (CBT) in preventing weight regain after treatment for obesity. Of the 43 obese patients who met the eligibility criteria, 40 (18 in the MF group and 22 in the CBT group) completed the 34 group sessions, which were given once a week for eight months. The average weight loss rate was 13.9% in the MF group and 16.5% in the CBT group, showing no significant difference between the groups. For eating behavior, restrained eating was significantly increased and emotional and external eating were significantly decreased in both groups after treatment. MF traits were significantly reinforced in both groups. The number of participants will be increased in the future, and the effectiveness of these treatment modalities for preventing weight regain will be verified by following the patients for two years after the end of treatment.
|
| Academic Significance and Societal Importance of the Research Achievements |
マインドフルネスを集団で実施し、減量および体重維持効果が明らかになれば、コストパフォーマンスの点で個人療法に対する優位性から、医療政策に対する新たな提言を可能にする。同時に、肥満関連疾患の予防および医療経済学的にも大きな貢献を果たすと考える。しかも海外においてマインドフルネスの長期におよぶ減量維持治療についての無作為化比較試験は我々が知り得る限り報告はなされておらず、今回の研究は、本邦のみならず世界の肥満治療を進歩させる上でも、非常に意義深いものであると考えられる。
|
